Send To friend

Please type in Friend Name
Please enter only Characters
Please type in Friend Email
Please enter a valid EmailID
Please type in Your Name
Please enter only Characters
Please type in Your Email
Please enter a valid EmailID

Thank You

Thank you for submitting your feedback. We shall revert to you shortly.

Back
 
>
>
> Cancer Chemotherapy
  • Hematological Malignancies
  • Genitourinary malignancies with special interest in testicular/ovarian and prostate malingnancies
  • Sarcomas
  • He is also involved in clinical research since 2005 and trained in ICH GCP guidelines for the same
  • Breast Cancer.
  • Autologous Bone Marrow / Transplantation with special interest in High Dose Chemotherapy and Stem Cell Rescue.
  • Gastrointestinal and Colorectal Tumors.
  • Pediatric Malignancies.
  • Special Interest in Immunotherapy.

Dr. Sachin Almel has been associated with Department of Medical Oncology, P.D. Hinduja National Hospital & Medical Research Centre, Mumbai since July 1995.

Educational Qualification:

1988 - M.B.B.S., South Gujarat University

1992 - M.D. (Internal Medicine), South Gujarat University

1995 - D.M. (Onco Medicine) , Gujarat University

Experience:

Date

Post Held

Institute

02.04.2000 onwards

Consultant Medical Oncologist

P.D. Hinduja National Hospital & Medical Research Centre, Mumbai

20.01.1997 – 01.04.2000

Associate Consultant

P.D. Hinduja National Hospital & Medical Research Centre, Mumbai

07.07.1997 – 07.09.1997

‘Fellow’ Varoon Mahajan Memorial Trust Inc.

CORNELL University

Medical College, New York, USA

13.07.1995 – 19.01.1997

Clinical Associate

P.D. Hinduja National Hospital & Medical Research Centre, Mumbai

01.05.1995 – 12.07.1995

Junior Lecturer

Gujarat Cancer & Research Institute, Ahmedabad, Gujarat

30.01.1993 – 30.04.1995

Resident Doctor in Medical Oncology

Gujarat Cancer & Research Institute, Ahmedabad, Gujarat

01.09.1989 – 28.01.1993

Resident Doctor in Internal Medicine

Government Medical College, Surat, Gujarat

 

He has also been involved in various clinical trials conducted at the Institute, the most notable being the MCP-841 and MCP-842 trials in collaboration with National Cancer Institute, U.S.A. for Acute Leukemia and High Grade Non-Hodgkin's lymphomas. During his basic training in department of Internal Medicine, he has worked in-

  • Department of Cardiology for 3 months
  • Department of Pulmonary Diseases for 3 months
  • Department of Nephrology for 3 months

He has also worked for 3 months in the casualty department and has an adequate knowledge of handling emergency cases.

Clinical Trials Experience:

No. of years of experience in clinical trials: 5 Years

  • Project Title: A Randomized, Double-Blind, and Multicentere Study of xxx Compared with Zoledronic Acid (Zometa) in the Treatment of Bone Metastases in subjects with Prostrate Cancer 

              PI: DR ASHA KAPADIA

             CO-PI: DR SACHIN V ALMEL

  • Project Title: A Randomized phase 2 Trial of Double-Blind, Placebo Controlled xxx in Combination with Paclitaxel, as First Line Therapy in Women with HER2Negative Locally Recurrent or Metastatic Breast Cancer

              PI: DR SACHIN ALMEL

             CO-PI:DR ASHA KAPADIA

  • Project Title: A Randomised, Double-Blind, Placebo-Controlled, Multicentre, Phase III Study of Post - Operative Adjuvant XXX or Placebo and Concurrent Chemoradiotherapy Followed by Maintenance XXX or Placebo Monotherapy in High-Risk Subjects with Resected Squamous Cell Carcinoma of Head and Neck (SCCHN).”

              PI: DR SACHIN ALMEL

             CO-PI: DR ASHA KAPADIA

 
  • Project Title: A multicentere, open-label, phase II study of XXX XXX for efficacy and Safety in patients with Metastatic breast cancer

              PI: DR SACHIN ALMEL

             CO-PI: DR ASHA KAPADIA

 
  • Project Title: A Randomized, Open-Label, Multicenter, Phase 3 Study of xxx Plus Standard Supportive Care versus Standard Supportive Care in   Anemic Patients with Metastatic Breast Cancer Receiving Standard Chemotherapy

              PI: DR SACHIN ALMEL

             CO-PI: DR ASHA KAPADIA

 
  • Project Title: A Phase 1b / 2 Trial of XXX or XXX in Combination with Platinum-based    Chemotherapy      as First-Line Treatment for Extensive Stage Small Cell Lung Cancer”

             PI: DR SACHIN ALMEL

            CO-PI: DR ASHA KAPADIA

 
  • Project Title: A Phase 3, Randomized, Double-Blinded Study of xxxxxxxxxx and Best Supportive Care (BSC) Versus Placebo and BSC in the Treatment of Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Following Disease Progression on First-Line Platinum- or Fluoropyrimidine-Containing Combination Therapy

             PI: DR SACHIN ALMEL

            CO-PI: DR ASHA KAPADIA

 
  • Project Title: A Phase 3, randomized, double-blind, placebo-controlled study of oral xxx in addition to best supportive care in patients with non-small cell lung cancer who have failed two or more prior treatment regimens

              PI: DR SACHIN ALMEL

             CO-PI: DR ASHA KAPADIA

 
  • A Randomized, Double-Blind, Placebo-Controlled, Multi-Center Phase 3 Study of xxxxxxxx as Adjuvant Treatment for Women with Early-Stage Breast Cancer at High Risk of Recurrence (D-CARE).

             PI: DR SACHIN ALMEL

            CO-PI: DR ASHA KAPADIA

ICH-GCP Training:

Has Received ICH-GCP Training at PI meet held at Bangkok on 26th and 27th July 2008

Room NoMondayTuesdayWednesdayThursdayFridaySaturday
0106 08:00-13:30, F 14:00-15:00, 15:00-18:0008:00-13:30, F 14:00-15:00, 15:00-18:0008:00-13:30, F 14:00-15:00, 15:00-18:0008:00-13:00, F 13:00-14:0008:00-13:30, F 14:00-15:00, 15:00-18:0008:00-10:00, 10:00-12:30 (PRIVILEGE CLINIC)

F - Free OPD

Consultants